Address: Universiteitssingel 50 kamer 3.208, 6229 ER Maastricht, The Netherlands
Skype ID: hhhw_schmidt
Chair of the Action
Harald is Professor & Chair of Pharmacology & Personalised Medicine at the Cardiovascular Research Institute Maastricht, co-leader of Maastricht University’s Faculty of Health, Medicine and Life Sciences innovation platform, and Board Member of the Maastricht Institute of Advanced Studies at Maastricht University, Netherlands. He leads a research program as European Research Council Advanced Investigator, a EUROSTAR programme, and founded the European Science Foundation COST Action, EU-ROS. Before he had worked in Australia, Germany and USA in different academic and business leadership positions. These include chair of Monash University’s Centre for Vascular Health, Australia, different chairs in pharmacology and director of a drug discovery CRO at TransMIT, Giessen, Germany. He also co-founded and for two years led as CEO Vasopharm GmbH, a drug discovery company now entering into phase III clinical development. His research focuses on cardiovascular and neurological disease mechanisms, target validation, drug and biomarker discovery, personalised and network medicine. Harald has published over 160 peer-reviewed papers, reviews, books (Hirsch-index of 75, m=2.7; Google-Scholar: tinyurl.com/q4july7) and holds several patents. In this action he wishes to lift his research on the validation and application of the diseasome-based common mechanism concept to a higher and more interdisplinary level to achieve the many many opportunities for re-definition of disease and drug repositioning.